Search Blog
November 2013
« Oct   Dec »


Letter to Shareholders of NaturalNano, Inc.


By Issuer Direct

ROCHESTER, NY- (Accesswire – November 14, 2013) – NaturalNano, Inc. (OTCQB: NNAN) ( – Mr. Jim Wemett, CEO of NaturalNano Inc. (OTCBB:NNAN), made the following announcement:  

Dear Shareholders,

In an effort to continually keep our shareholders and interested parties informed on progress made and significant developments with the Company’s business, the Management of NaturalNano Inc. is pleased to provide you with this update.

Great progress continues to be made with new product lines using our patented proprietary Halloysite NanoTubes (HNT). Our on-going ventures with some international firms allows us to identify new applications for HNT and then to establish on-going relationships with these partners during the commercialization process  generating revenue for NNAN.  Over the next year we expect to continue these early stage programs and introduce several new products for current and potential customers.

NaturalNano has established a strategic relationship to develop an advanced material used in armor that incorporates NNAN’s proprietary Halloysite NanoTubes (HNT).  Our nano-scale additive is highly reliable and increases the yield strength.  As a result of this collaboration, the first product utilizing HNT in the armor market has recently shipped to customers. We are excited to be a part of this kick off and look forward to a long term relationship with the marketer and many future orders for our HNT.

In 2012, we extended our arrangement with Fiabila S.A., a world leader in private label nail polish manufacture, three more years for their continued use of our patented technology of HNT tubes in lines of their commercially successful nail polish products.  The latest product is for a customer who has a major nail polish line manufactured by Fiabila which is sold at the largest retailers in the USA, including Target, Wal-Mart, CVS and Walgreen’s.  Their new market expansion of those lines into European Markets will also continue to feature NNAN’s patented HNT technology. In 2013, they placed their largest orders for HNT which resulted in a 60% increase over the previous year’s purchase of HNT.  We expect this trend to continue into 2014 as they expand distribution to the European Union markets.
NaturalNano also continues to invest in expanding its patent portfolio. This strengthens our position as the world leader in the industrial applications for Halloysite and enables us to protect novel uses that expand our licensing opportunities. Our patents now cover the current projects and products that we have enabled our commercial customers to market.

NaturalNano maintains a 9300 sq. ft. commercial base in Rochester, NY that house our proprietary HNT processing facility.  It has extensive lab facilities which have the equipment required for our commercial operations.  Pictures of the facility can be viewed our web site .

We continue to explore applications of HNT in the life sciences. Work, at Cornell University in Ithaca NY with Dr. Michael King’s laboratory, continues to evaluate the use of HNT as a surface treatment to assess it’s ability to increase surface areas. Dr. King’s work with NaturalNano’s HNT continues to build on our understanding of the potential role this may play in life science applications. A video of his work can be viewed at a scientific web site:  

Over the next several months, we will be updating our website to make it more informative and to provide Shareholders with expanded content.  

Have a Great Holiday Season,
Jim Wemett, CEO

NaturalNano, Inc. (OTCBB: NNAN) is a materials science company focused on developing and commercializing advanced nanocomposites. The Company is focused on additive technologies and processes, including its proprietary Pleximer that adds value to industrial polymers, plastics and composites. NaturalNano holds and/or licenses over 10 patents and applications relating to Halloysite, as well as proprietary know-how for its extraction and separation processes, compositions, and derivatives.

Cautionary Statement Regarding Forward-Looking Statements: Contains forward-looking statements regarding future events and future performance that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano’s filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-K and quarterly reports on Form 10-Q filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by

Jim Wemett
NaturalNano, Inc.